Extraordinary is a New Zealand company that runs a flexible health and wellbeing allowance platform for employers.
Employers set a contribution and the categories it can be spent on, and each employee gets an app and a personalized Mastercard that only works in the approved sectors, covering perks such as healthcare, wellbeing, public transport, and rewards. Founded as HealthNow in 2021 and renamed in October 2024.
Restricting the card at the merchant category rather than policing receipts afterwards is what makes the whole model work. Employers are charged only when an allowance is actually spent, so the cost of a benefit finally matches its take-up instead of its headcount.
NZVC invested in Extraordinary from NZVC Fund I. We file the company under Fintech on the portfolio wall.
We backed Extraordinary because employee benefits are still delivered through clunky reimbursements and one-size-fits-all schemes, and employers want flexible perks their diverse workforces will actually use. The smart card and app turn a manual admin burden into a controlled, spend-when-used product, which aligns cost with real usage and lifts take-up. The founder had already proven the model in health and wellbeing, and demand for meaningful, flexible benefits is growing as employers compete harder for people.

You hear three founders describe what it takes to build fintech in a country where four Australian banks own the market. Jovan Pavlicevic on lobbying to start a bank, Dermot Butterfield on open banking pipes, and Steven Zinsli on making public transport tax-free through product design.
A joint episode, alongside SquareOne and Wych.
You hear five founders in twelve minutes on the parts of startups that do not make the highlight reels. Shaun Quincey on finding the real buyer, Liam Kampshof on cowshed prototypes, Steven Zinsli on stopping what is wrong, Nick Damiano on deciding to found, and Anna Henwood on loving uncertainty.
A joint episode, alongside Simfuni, Bovonic, Andromeda Surgical and Stickybeak.
You hear how a 27-year-old sold a 15-clinic health group and then killed his own healthcare BNPL idea. Steven Zinsli explains the pivot to employer benefits, why breakage beats card fees, and how a tax ruling on public transport became Extraordinary's moat.
“Persist more than resist.”Steven Zinsli